Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MIRA Pharmaceuticals, Inc. - Common Stock (NQ:MIRA)

1.800 +0.480 (+36.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 114,087,283
Open 2.340
Bid (Size) 1.670 (46)
Ask (Size) 1.680 (42)
Prev. Close 1.320
Today's Range 1.650 - 2.450
52wk Range 0.7300 - 2.560
Shares Outstanding 19,069,315
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are experiencing notable movement on Thursday?
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data
MIRA Pharmaceuticals shares are trading significantly higher on Thursday following the announcement of new preclinical data for its lead candidate Mira-55. 
Via Benzinga

Performance

YTD
+56.5%
+56.5%
1 Month
+30.4%
+30.4%
3 Month
-3.7%
-3.7%
6 Month
+68.2%
+68.2%
1 Year
+71.4%
+71.4%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Dips Over 100 Points; US Crude Oil Inventories Surge
Via Benzinga
Topics Stocks
Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making
Via Stocktwits
Top movers analysis in the middle of the day on 2025-10-16: top gainers and losers in today's session.
Via Chartmill
Thursday's session: gap up and gap down stocks
Via Chartmill
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain
Via ACCESS Newswire
Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Mira Pharmaceuticals Shares Rose 69% After Hours?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Wednesday's after hours session: top gainers and losers
Via Chartmill
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction
Via ACCESS Newswire
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
Via ACCESS Newswire
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
Via ACCESS Newswire
Monday's after hours session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
Via ACCESS Newswire
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Via ACCESS Newswire
MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin
Via ACCESS Newswire
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Via ACCESS Newswire
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
Via ACCESS Newswire

Frequently Asked Questions

Is MIRA Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, MIRA Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does MIRA Pharmaceuticals, Inc. - Common Stock trade on?
MIRA Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MIRA Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for MIRA Pharmaceuticals, Inc. - Common Stock is MIRA on the Nasdaq Stock Market
What is the current price of MIRA Pharmaceuticals, Inc. - Common Stock?
The current price of MIRA Pharmaceuticals, Inc. - Common Stock is 1.800
When was MIRA Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of MIRA Pharmaceuticals, Inc. - Common Stock was at 10/16/25 04:00 PM ET
What is the market capitalization of MIRA Pharmaceuticals, Inc. - Common Stock?
The market capitalization of MIRA Pharmaceuticals, Inc. - Common Stock is 34.32M
How many shares of MIRA Pharmaceuticals, Inc. - Common Stock are outstanding?
MIRA Pharmaceuticals, Inc. - Common Stock has 34M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.